These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31624593)

  • 1. γδ T cells in cancer: a small population of lymphocytes with big implications.
    Raverdeau M; Cunningham SP; Harmon C; Lynch L
    Clin Transl Immunology; 2019; 8(10):e01080. PubMed ID: 31624593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
    Rei M; Pennington DJ; Silva-Santos B
    Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-delta (γδ) T cells: friend or foe in cancer development?
    Zhao Y; Niu C; Cui J
    J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy.
    Lee D; Rosenthal CJ; Penn NE; Dunn ZS; Zhou Y; Yang L
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.
    Schönefeldt S; Wais T; Herling M; Mustjoki S; Bekiaris V; Moriggl R; Neubauer HA
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
    J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity.
    Lee HW; Chung YS; Kim TJ
    Immune Netw; 2020 Feb; 20(1):e5. PubMed ID: 32158593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
    Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
    Front Immunol; 2018; 9():1990. PubMed ID: 30298063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory role of Vγ1 γδ T cells in tumor immunity through IL-4 production.
    Hao J; Dong S; Xia S; He W; Jia H; Zhang S; Wei J; O'Brien RL; Born WK; Wu Z; Wang P; Han J; Hong Z; Zhao L; Yin Z
    J Immunol; 2011 Nov; 187(10):4979-86. PubMed ID: 21987661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producers.
    Shibata K; Yamada H; Nakamura R; Sun X; Itsumi M; Yoshikai Y
    J Immunol; 2008 Nov; 181(9):5940-7. PubMed ID: 18941182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
    Li J; Cao Y; Liu Y; Yu L; Zhang Z; Wang X; Bai H; Zhang Y; Liu S; Gao M; Lu C; Li C; Guan Y; Tao Z; Wu Z; Chen J; Yuan Z
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ-producing and IL-17-producing γδ T cells differentiate at distinct developmental stages in murine fetal thymus.
    Shibata K; Yamada H; Nakamura M; Hatano S; Katsuragi Y; Kominami R; Yoshikai Y
    J Immunol; 2014 Mar; 192(5):2210-8. PubMed ID: 24489104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17-Producing Innate and Pathogen-Specific Tissue Resident Memory γδ T Cells Expand in the Lungs of Bordetella pertussis-Infected Mice.
    Misiak A; Wilk MM; Raverdeau M; Mills KH
    J Immunol; 2017 Jan; 198(1):363-374. PubMed ID: 27864475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Responsiveness of Innate-like IL-17- and IFN-γ-Producing γδ T Cells to Homeostatic Cytokines.
    Corpuz TM; Stolp J; Kim HO; Pinget GV; Gray DH; Cho JH; Sprent J; Webster KE
    J Immunol; 2016 Jan; 196(2):645-54. PubMed ID: 26673141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells.
    Haas JD; González FH; Schmitz S; Chennupati V; Föhse L; Kremmer E; Förster R; Prinz I
    Eur J Immunol; 2009 Dec; 39(12):3488-97. PubMed ID: 19830744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γδ T cells in infection and autoimmunity.
    Hou L; Wang T; Sun J
    Int Immunopharmacol; 2015 Oct; 28(2):887-91. PubMed ID: 25864620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.
    Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T
    Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Tr1 cytokine profiles.
    Seo N; Tokura Y
    J Interferon Cytokine Res; 1999 Jun; 19(6):555-61. PubMed ID: 10433355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Advances in γδ T Cell-Based Tumor Immunotherapy.
    Lo Presti E; Pizzolato G; Gulotta E; Cocorullo G; Gulotta G; Dieli F; Meraviglia S
    Front Immunol; 2017; 8():1401. PubMed ID: 29163482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.